ImageneBio (IMA) Operating Expenses (2020 - 2024)
Historic Operating Expenses for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to $24.6 million.
- ImageneBio's Operating Expenses rose 907.52% to $24.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $64.2 million, marking a year-over-year decrease of 2409.28%. This contributed to the annual value of $59.0 million for FY2024, which is 3027.3% down from last year.
- ImageneBio's Operating Expenses amounted to $24.6 million in Q4 2024, which was up 907.52% from $5.5 million recorded in Q3 2024.
- Over the past 5 years, ImageneBio's Operating Expenses peaked at $26.1 million during Q4 2020, and registered a low of $5.5 million during Q3 2024.
- In the last 5 years, ImageneBio's Operating Expenses had a median value of $19.3 million in 2021 and averaged $17.7 million.
- In the last 5 years, ImageneBio's Operating Expenses skyrocketed by 10158.91% in 2021 and then plummeted by 7324.05% in 2024.
- Quarter analysis of 5 years shows ImageneBio's Operating Expenses stood at $26.1 million in 2020, then plummeted by 33.28% to $17.4 million in 2021, then increased by 18.01% to $20.6 million in 2022, then rose by 9.74% to $22.6 million in 2023, then increased by 9.08% to $24.6 million in 2024.
- Its Operating Expenses stands at $24.6 million for Q4 2024, versus $5.5 million for Q3 2024 and $15.8 million for Q2 2024.